MGNX MACROGENICS INC

NEUTRAL Impact: 3/10 Institutional Cluster
Horizon weeks Processed 2d 1h ago
Institutional cluster: 4 buyers, 1 sellers (bullish)

Executive Summary

Four institutions increased their MGNX positions in Q3 2025 while one reduced, resulting in net buying of approximately $2M. However, the buying is dominated by passive managers (Morgan Stanley, Wells Fargo, Invesco) and quant fund RenTech, suggesting index rebalancing or quantitative signals rather than fundamental conviction. The sole seller, Schwab, nearly exited its position. Given the small absolute dollar amounts and passive nature, the signal is weak.

Key Financial Metrics

Direction
accumulating
Buy Value
$4.7M
Sell Value
$405.0K
Net Flow
$2.0M

Institutional Positions

Net institutional flow: $2.0M

▲ Buyers (4)

InstitutionActionChangePosition ValueValue Δ
Morgan Stanley DOUBLED +121.7% $1.7M $1.1M
RenTech ADD +28.2% $2.9M $1.3M

▼ Sellers (1)

InstitutionActionChangePrev ValueValue Δ
Schwab NEAR_EXIT -91% $405.0K -$354.1K

Actionable Insight

The cluster is dominated by passive rebalancing; active manager interest is absent. Monitor for 13F filings from active funds or insiders to gauge genuine conviction. The 45-day reporting lag means these positions are already stale.

Key Facts

  • Morgan Stanley doubled its MGNX holdings (446K → 989K shares, value $540K → $1.7M).
  • RenTech added 28.2% (1.33M → 1.70M shares, value $1.6M → $2.9M).
  • Schwab reduced its stake by 91% (334K → 30K shares, value $405K → $50K).
  • Net institutional buying of ~$2.0M, but mostly from passive index funds.
  • MGNX market cap is $246M; the cluster represents a tiny fraction of outstanding shares.

Financial Impact

4 buyers accumulated $2.4M in new positions while 1 seller reduced holdings by $354K, net +$2.0M.

institutional ownershipfloat

Risk Factors

  • Passive buying may be reversed in subsequent quarters with no fundamental catalyst.
  • Small dollar amounts relative to market cap limit price impact.
  • Historical win rate on MGNX reports is 40% at T+20, suggesting unreliable signal.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
62% bullish (13 analysts)

Documents Analyzed

This report is based on 1 institutional 13F filing from SEC EDGAR.

DocumentAccession Number
INST-CLUSTER Data (Synthetic)inst-cluster-MGNX-2025-Q3
9 reports for MGNX
Performance horizon
100% Hit rate 5 of 5 directional calls best @ T+60▲ +130.41%Feb 28, 2026
Filters
Rows
Reports for MGNX — sortable, filterable
Type Now
Jun 12, 2026
1d ago
Institutional Cluster
MIXED ★ 6/10
$4.01 awaiting T+5awaiting T+5
Jun 11, 2026
2d ago
Institutional Cluster
NEUTRAL ★ 3/10
$3.87 awaiting T+5awaiting T+5
May 13, 2026
4w ago
8-K
BULLISH ★ 7/10
$4.16 $4.24▲ +1.92%▲ +2.64%
May 12, 2026
4w ago
8-K
BULLISH ★ 7/10
$3.52 $4.35▲ +23.58%▲ +23.50%
May 11, 2026
4w ago
Press Release
MIXED ★ 6/10
$3.52 $4.35▲ +23.58%▲ +23.50%
Apr 8, 2026
9w ago
8-K
BULLISH ★ 7/10
$3.44 $3.41▼ −0.87%▼ −4.06%
Apr 8, 2026
9w ago
Press Release
BULLISH ★ 7/10
$3.44 $3.41▼ −0.87%▼ −4.06%
Apr 8, 2026
9w ago
DEFA14A
NEUTRAL ★ 2/10
$3.44 $3.41▼ −0.87%▼ −4.06%
Feb 28, 2026
15w ago
Institutional Cluster
BULLISH ★ 6/10
$1.94 $2.36▲ +21.65%▲ +22.86%
Showing 9 of 9

US Market Status

Market Closed — Opens Mon (47h 37m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access